EPISODE · Nov 21, 2023 · 21 MIN
SGLT2 Inhibitors and Continuation of Renin Angiotensin Blockade
from Journal of the American Society of Nephrology (JASN) · host American Society of Nephrology
Dr. Briggs and Brendon Neuen discuss his paper in the December issue of JASN. This article on the CREDENCE and EMPA-CKD clinical trials shows that SGLT2 inhibitors allow more consistent use of RAS blockade in patients with declining renal function.
Embed this episode
NOW PLAYING
SGLT2 Inhibitors and Continuation of Renin Angiotensin Blockade
0:00
21:23
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Journal of the American Society of Nephrology (JASN)?
This episode is 21 minutes long.
When was this Journal of the American Society of Nephrology (JASN) episode published?
This episode was published on November 21, 2023.
Is there a transcript available for this episode?
Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.
Can I download this Journal of the American Society of Nephrology (JASN) episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!